Kevin Berry in Issaquah, Washington

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Kevin Berry is listed as: Physical Medicine And Rehabilitation
Approximate Years of Experience: 17
PAC (PECOS ID)#: 3971740945
NPI #: 1083889638
NPI Created On: 04/24/2008
NPI Last Updated Listed as: 06/27/2021
Primary Taxonomy Code: 208100000X
License Number:
MD60387536
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Injections of trigger points in 1 or 2 muscles
2. Aspiration and/or injection of large joint or joint capsule
3. Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance
4. Injection of substance into spinal canal of lower back or sacrum using imaging guidance
5. Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance
6. Injections of lower or sacral spine facet joint using imaging guidance
7. Injections of lower or sacral spine facet joint using imaging guidance
8. Destruction of lower or sacral spinal facet joint nerves using imaging guidance
9. Destruction of lower or sacral spinal facet joint nerves with imaging guidance
10. Ultrasonic guidance imaging supervision and interpretation for insertion of needle
11. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Injection, triamcinolone acetonide, not otherwise specified, 10 mg
17. Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
18. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r